Extraintestinal cancers in inflammatory bowel disease
- PMID: 4052961
- DOI: 10.1002/1097-0142(19851215)56:12<2914::aid-cncr2820561232>3.0.co;2-j
Extraintestinal cancers in inflammatory bowel disease
Abstract
The case histories of 1961 patients with inflammatory bowel disease (IBD), 1227 with Crohn's disease (CD) and 734 with ulcerative colitis (UC), have been studied for the incidence of extraintestinal malignant neoplasms. There were 54 extraintestinal cancers in 51 patients: 28 patients with CD and 23 with UC; 25 men and 26 women. There were 9 breast, 7 skin, 15 reticuloendothelial, 11 genitourinary, 3 lung, 3 perianal, 2 pancreatic islet cell, and several miscellaneous cancers. The number of patient-years from the onset of disease to the last date of follow-up was calculated for men and women with each form of IBD. The observed number (O) of neoplasms was recorded. The expected number (E) of neoplasms was derived from the Department of Health, Education, and Welfare (DHEW) incidence figures for the same neoplasms that occurred in a standard age- and sex-matched population. The O/E ratio was then calculated for each type of cancer as well as for the entire series. There were no statistically significant increases in overall O/E ratios of extraintestinal cancers for either CD (0.76) or UC (1.32). On the other hand, several specific types of cancer did appear to occur with a frequency that was significantly greater than expected. These cancers were classified into two groups. The first group included reticuloendothelial neoplasms. There was an excess of leukemias in UC (P less than 0.005) and an excess of lymphomas in both UC and CD (P less than 0.005). The second group included three squamous cell cancers of the perianal region, an incidence 30 times greater than expected, and two squamous cell cancers of the vagina, also in excess of the expected number. Lymphoma, leukemia, and squamous cell cancers have been reported to occur in excess in immunosuppressed or irradiated patients. It may therefore be speculated that the apparently increased incidence of these neoplasms in the patients with ileitis and colitis might be related to immunologic deficiencies associated with IBD, to the long-term administration of steroids or other immunosuppressive medications that were given to most of the patients or, possibly, to increased exposure to ionizing radiation. The apparently increased incidence of perianal and vaginal cancers of the squamous variety might be a consequence of the combined effects of chronic inflammatory disease involving these areas and primary immune suppression.
Similar articles
-
Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.Am J Gastroenterol. 2016 Oct;111(10):1428-1436. doi: 10.1038/ajg.2016.304. Epub 2016 Aug 2. Am J Gastroenterol. 2016. PMID: 27481308
-
Intestinal and extraintestinal neoplasia in patients with inflammatory bowel disease in a tertiary care hospital.Arq Gastroenterol. 2013 Apr;50(2):123-9. doi: 10.1590/s0004-28032013000200021. Arq Gastroenterol. 2013. PMID: 23903622
-
Increasing Risk of Lymphoma Over Time in Crohn's Disease but Not in Ulcerative Colitis: A Scandinavian Cohort Study.Clin Gastroenterol Hepatol. 2023 Nov;21(12):3132-3142. doi: 10.1016/j.cgh.2023.04.001. Epub 2023 Apr 13. Clin Gastroenterol Hepatol. 2023. PMID: 37061104
-
The epidemiology of inflammatory bowel disease.Scand J Gastroenterol. 2015 Aug;50(8):942-51. doi: 10.3109/00365521.2015.1014407. Epub 2015 Feb 17. Scand J Gastroenterol. 2015. PMID: 25687629 Review.
-
The Risk of Extraintestinal Cancer in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Cohort Studies.Clin Gastroenterol Hepatol. 2021 Jun;19(6):1117-1138.e19. doi: 10.1016/j.cgh.2020.08.015. Epub 2020 Aug 13. Clin Gastroenterol Hepatol. 2021. PMID: 32801010
Cited by
-
Langerhan's cell histiocytosis complicating small bowel Crohn's disease.Gut. 1996 Feb;38(2):296-8. doi: 10.1136/gut.38.2.296. Gut. 1996. PMID: 8801215 Free PMC article.
-
Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County.Gut. 2004 Jun;53(6):849-53. doi: 10.1136/gut.2003.018515. Gut. 2004. PMID: 15138212 Free PMC article.
-
Risk of Cancer in Inflammatory Bowel Disease and Pitfalls in Oncologic Therapy.J Gastrointest Cancer. 2023 Jun;54(2):357-367. doi: 10.1007/s12029-022-00816-0. Epub 2022 Mar 14. J Gastrointest Cancer. 2023. PMID: 35288863 Review.
-
Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review.Cancers (Basel). 2023 Jul 27;15(15):3824. doi: 10.3390/cancers15153824. Cancers (Basel). 2023. PMID: 37568640 Free PMC article. Review.
-
Thiopurines in inflammatory bowel disease revisited.World J Gastroenterol. 2013 Mar 21;19(11):1699-706. doi: 10.3748/wjg.v19.i11.1699. World J Gastroenterol. 2013. PMID: 23555158 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Medical